RLFTF Quote Trading Chart Mondobiotech Holding AG Basel

$0.03 Last:

2.42% Change Percent:

$0.0293 Open:

$0.02929 Previous Close:

$0.0304 High:

$0.028 Low:

889,233 Volume:

12/31/1969 07:00:00 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Stock Date	Open Price	Close Price	High	Low	Volume
2022-10-06	0.0293	0.02929	0.0304	0.028	889,233
2022-10-05	0.0297	0.02929	0.03	0.028	564,034
2022-10-04	0.03	0.02945	0.0305	0.0273	1,067,036
2022-10-03	0.021	0.0275	0.03	0.021	783,585
2022-09-30	0.02845	0.02725	0.0299	0.0265	367,085
2022-09-29	0.028	0.026	0.03	0.02579	946,620
2022-09-28	0.02805	0.028575	0.0307	0.0255	2,144,262
2022-09-27	0.023	0.0269	0.0285	0.023	1,234,884
2022-09-26	0.0282	0.028	0.0299	0.0237	1,431,655
2022-09-23	0.025	0.03	0.031	0.025	1,310,306
2022-09-22	0.0229	0.03054	0.0321	0.0229	1,749,314
2022-09-21	0.0285	0.0287	0.032	0.027	1,187,441
2022-09-20	0.032	0.0306	0.033	0.0302	612,331
2022-09-19	0.03169	0.032	0.033	0.0301	878,279
2022-09-16	0.0345	0.03285	0.0345	0.0318	1,262,974
2022-09-15	0.0329	0.0344	0.0346	0.031	1,622,934
2022-09-14	0.0347	0.033	0.0347	0.032	884,450
2022-09-13	0.0286	0.0332	0.0348	0.0286	825,080
2022-09-12	0.0346	0.03475	0.03475	0.03194	501,386
2022-09-09	0.03315	0.0318	0.0347	0.0318	848,374

Stock Information

Mondobiotech Holding AG Basel Company Name:

RLFTF Stock Symbol:

OTC Market:

Get RLFTF Alerts

News, Short Squeeze, Breakout and More Instantly...

RLFTF - Relief Announces Exclusive Distributor for PKU GOLIKE in the U.S.

Leading Provider of Food for Special Medical Purposes to Help Maximize Patient Access in Support of PKU GOLIKE ® U.S. Launch GENEVA, SWITZERLAND / ACCESSWIRE / October 6, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ("Relief"), a Swiss, commercial-sta...
RLFTF - Acer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Covering a Kit Comprising Phenylbutyrate and Sodium Benzoate

NEWTON, Mass. and GENEVA, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER) (Acer) and RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief) today announced that the US Patent and Trademark Office (USPTO) has issued a Notice of Allowance to Acer for U...
RLFTF - Relief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated Trial of Nexodyn for Epidermolysis Bullosa at Ann & Robert H. Lurie Children's Hospital of Chicago

Professor Amy Paller, M.D., will serve as Principal Investigator to evaluate Nexodyn for the management of colonized dystrophic and junctional Epidermolysis Bullosa wounds, an important unmet need in this group of rare inherited skin diseases that affects approximately 250,000 patients...